Arttu Uoti

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform

J. Karbach, A. Kreutzman, V. Cerullo, 2021, Molecular therapy oncolytics.

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

V. Cerullo, T. Viitala, S. Feola, 2022, Molecular therapy oncolytics.

A personalized anti-cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

V. Cerullo, T. Viitala, S. Feola, 2021, bioRxiv.